Last reviewed · How we verify
NCT06249646
Contained Hepatic Vascular Injuries Following Liver Trauma
trial in Hepatic Injury in 318 participants. Completed in 31 March 2023.
31 October 2022
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nice |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 318 |
| Start date | 1 January 2022 |
| Primary completion | 31 October 2022 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across France |
Conditions studied
- Hepatic Injury — all drugs for Hepatic Injury →
- Liver Injury — all drugs for Liver Injury →
- Pseudoaneurysm — all drugs for Pseudoaneurysm →
Sponsor
Centre Hospitalier Universitaire de Nice
Who can join
15 and older, any sex, with Hepatic Injury or Liver Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: For thirty years, a major shift in the management of liver trauma has been seen. Contained hepatic vascular injuries (CHVI), including pseudo aneurysms and arteriovenous fistula, are often feared due to their risk of secondary bleeding. Nonetheless, knowledge of CHVI is scarce and no guidelines on their management have been set. The investigators aimed to validate the risk factors of CHVI, identify associated morbidities, and establish a management protocol. Study Design: A retrospective study on 318 liver trauma from a level 1 trauma center over the last 15 years, comparing the presence or not of CHVI. Univarious and multivarious analyses were performed. A comparison of the management of CHVI was also performed.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Contained hepatic vascular injuries following liver trauma: a retrospective monocentric study and review of the literature.
Frey S, Bentellis I, Sedat J, Poirier F, et al · · 2024 · PMID 38963726 · DOI 10.1097/js9.0000000000001827
Verify or expand the search:
- PubMed search for NCT06249646
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre Hospitalier Universitaire de Nice trials
Trials by the same sponsor.
- NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
- NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
- NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
- NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
- NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06249646 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
- Last refreshed: 8 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06249646.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing